ORAMED PHARMACEUTICALS INC.
For the period ended Aug 19, 2025. Filed Jul 16, 2025.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Aug 19, 2025 · Filed Jul 16, 2025
Use the contents to explore the available documents and sections.
Contents
Board Evaluation Process
Our Board is committed to continuous improvement and conducts a board and committee evaluation process each year, to ensure that our Board maintains optimal composition and functions effectively.
As part of this process, the members of our Board complete a confidential written assessment of the performance, oversight and composition of the Board and its committees that is submitted to the Company secretary. The results are then reported back to the full Board. After the evaluations, the Board and management work to improve upon any issues presented during the evaluation process and to identify opportunities that may lead to further improvement.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.